PCOS and Ovarian Cysts: Are They Connected?

You've been told you have PCOS, or you've been told you have ovarian cysts, and you're wondering if they're the same thing. The names overlap, the symptoms overlap, and the confusion is understandable. But these are distinct conditions with different causes, treatments, and implications.

Key Takeaways

• PCOS is a hormonal disorder; ovarian cysts are fluid-filled sacs that form independently.
• The "cysts" in PCOS are actually immature follicles, not true cysts.
• PCOS involves elevated androgens and insulin resistance; most ovarian cysts do not.
• Bilateral ovarian follicles on ultrasound suggest PCOS but require hormonal confirmation.

What PCOS Actually Is (and What It Isn't)

Polycystic ovary syndrome is a metabolic and hormonal disorder, not simply a condition of the ovaries. The name is misleading. Women with PCOS don't have true cysts. What appears on ultrasound as multiple small "cysts" are actually immature follicles, fluid-filled sacs that contain developing eggs. In a typical menstrual cycle, one follicle matures and releases an egg during ovulation. In PCOS, hormonal imbalances prevent follicles from maturing. Instead, they accumulate in the ovaries, creating the characteristic "string of pearls" appearance on imaging.

The core issue is not the follicles themselves but the hormonal environment that prevents them from developing normally. Elevated levels of androgens like testosterone, combined with insulin resistance and disrupted signaling from luteinizing hormone (LH) and follicle-stimulating hormone (FSH), interfere with ovulation. The result is irregular or absent periods, difficulty conceiving, and a cascade of metabolic effects that extend far beyond the reproductive system.

Ovarian cysts, by contrast, are fluid-filled sacs that form on or inside the ovaries. Most are functional cysts, meaning they develop as a normal part of the menstrual cycle. A follicular cyst forms when a follicle doesn't release its egg and continues to grow. A corpus luteum cyst forms after ovulation when the structure that released the egg fills with fluid instead of dissolving. These cysts typically resolve on their own within one to three months and don't disrupt hormone levels or metabolism the way PCOS does.

How PCOS Affects Hormones, Metabolism, and Ovarian Function

Androgen excess and ovarian dysfunction

Women with PCOS produce higher than normal levels of androgens, primarily testosterone and androstenedione. This happens because the ovaries are overstimulated by elevated insulin and LH, both of which drive androgen synthesis in ovarian theca cells. High androgen levels interfere with normal follicle development, preventing eggs from maturing and being released. This creates a self-reinforcing cycle: anovulation leads to more follicles accumulating, which produces more androgens, which further suppresses ovulation.

Insulin resistance and hyperinsulinemia

Insulin resistance is present in up to 70% of women with PCOS, regardless of body weight. When cells become less responsive to insulin, the pancreas compensates by producing more. Elevated insulin has two major effects: it stimulates the ovaries to produce more androgens, and it reduces the liver's production of sex hormone-binding globulin (SHBG), the protein that binds and inactivates testosterone. The result is more free, biologically active testosterone circulating in the bloodstream.

Disrupted ovulation and menstrual irregularity

The hormonal imbalances in PCOS disrupt the normal feedback loop between the brain and ovaries. LH levels are often chronically elevated, while FSH remains relatively low. This ratio prevents follicles from receiving the signal to mature and ovulate. Without ovulation, progesterone isn't produced, and the uterine lining isn't shed in a regular pattern. This leads to irregular, infrequent, or absent periods, and increases the risk of endometrial hyperplasia over time.

Metabolic and cardiovascular effects

PCOS is associated with an increased risk of type 2 diabetes, metabolic syndrome, and cardiovascular disease. Insulin resistance drives fat storage, particularly visceral fat, which worsens inflammation and further impairs insulin sensitivity. Women with PCOS often have elevated triglycerides, low HDL cholesterol, and higher levels of inflammatory markers like high-sensitivity C-reactive protein. These metabolic changes begin early and accumulate over time, making early detection and management critical.

What Drives PCOS and Ovarian Cyst Formation

Genetic predisposition in PCOS

PCOS has a strong hereditary component. If your mother or sister has PCOS, your risk of developing it increases significantly. Research suggests that multiple genes involved in insulin signaling, androgen production, and ovarian function contribute to susceptibility. While no single gene causes PCOS, the condition tends to run in families, and women with a family history should be monitored for early signs like irregular periods or elevated androgens.

Are ovarian cysts genetic? Isolated functional cysts are not typically inherited. However, conditions that predispose women to cyst formation, such as PCOS or endometriosis, can have genetic components.

Insulin resistance and androgen production

Insulin resistance is both a driver and a consequence of PCOS. High insulin levels stimulate the ovaries to produce excess androgens, which interfere with normal follicle development. At the same time, elevated androgens worsen insulin resistance, creating a feedback loop. This is why interventions that improve insulin sensitivity, such as weight loss, exercise, or medications like metformin, can help restore ovulation and reduce androgen levels.

Lifestyle and environmental factors

Diet, physical activity, stress, and sleep all influence the severity of PCOS. Diets high in refined carbohydrates and sugar worsen insulin resistance. Chronic stress elevates cortisol, which can further disrupt reproductive hormones. Lack of physical activity reduces insulin sensitivity and promotes weight gain, particularly visceral fat, which exacerbates metabolic dysfunction. Environmental exposures to endocrine-disrupting chemicals may also play a role, though more research is needed.

Ovulatory dysfunction and cyst formation

Functional ovarian cysts form when normal ovulatory processes are disrupted. A follicular cyst develops when a follicle fails to rupture and release its egg. A corpus luteum cyst forms when the structure left behind after ovulation doesn't dissolve as expected. These cysts are common, often asymptomatic, and usually resolve without intervention. They don't indicate PCOS unless they occur in the context of other hormonal and metabolic abnormalities.

Why Ultrasound Findings Vary Between Women

Polycystic ovarian morphology vs. true cysts

On ultrasound, PCOS is characterized by bilateral ovarian follicles, typically 20 or more small follicles (2 to 9 mm in diameter) arranged around the periphery of each ovary, per the 2018 international PCOS guidelines. This is called polycystic ovarian morphology. The ovaries may also appear enlarged, with increased stromal volume. These findings reflect the accumulation of immature follicles, not true cysts.

Multiple follicles on ovaries ultrasound meaning depends on context. If you have 20 or more small follicles per ovary, along with irregular periods and elevated androgens, the diagnosis is likely PCOS. If you have one or two larger cysts (greater than 3 cm) without hormonal abnormalities, those are functional cysts, not PCOS.

Age and ovarian reserve

The number of follicles visible on ultrasound decreases with age as ovarian reserve declines. Younger women naturally have more follicles, which can make distinguishing between normal variation and PCOS more challenging. After age 30, the threshold for defining polycystic ovarian morphology may need to be adjusted. Older women with PCOS may have fewer visible follicles but still exhibit the hormonal and metabolic features of the syndrome.

Body composition and insulin sensitivity

Women with higher body fat, particularly visceral fat, are more likely to have severe insulin resistance and higher androgen levels. This worsens ovulatory dysfunction and increases the number of immature follicles visible on ultrasound. However, lean women can also have PCOS. In these cases, insulin resistance may be less pronounced, but androgen excess and ovulatory dysfunction are still present.

Hormonal contraceptive use

Birth control pills suppress ovulation and reduce androgen production, which can temporarily normalize ovarian appearance on ultrasound. If you've been on hormonal contraceptives, your ultrasound may not show polycystic ovarian morphology even if you have PCOS. Diagnosis requires stopping contraceptives for several months and reassessing both ultrasound findings and hormone levels.

Turning Imaging and Symptoms Into Actionable Data

An ultrasound showing bilateral ovarian follicles is only one piece of the diagnostic puzzle. PCOS is diagnosed using the Rotterdam criteria, which require at least two of the following: irregular or absent ovulation, clinical or biochemical signs of androgen excess, and polycystic ovarian morphology on ultrasound. Hormonal testing is essential. Elevated total testosterone, free testosterone, or androstenedione, along with an elevated LH to FSH ratio, support the diagnosis.

Metabolic markers add critical context. Testing fasting glucose, fasting insulin, and hemoglobin A1c reveals insulin resistance and prediabetes risk. Lipid panels, including triglycerides and HDL cholesterol, assess cardiovascular risk. Tracking these markers over time shows whether interventions are working. A single test tells you where you are; serial testing tells you whether you're moving in the right direction.

If you have an isolated ovarian cyst without hormonal abnormalities, follow-up ultrasound in six to eight weeks typically shows resolution. If the cyst persists or grows, or if you develop new symptoms like pelvic pain or abnormal bleeding, further evaluation is needed. Persistent or complex cysts may require additional imaging or surgical evaluation to rule out other conditions.

How Superpower Helps You Understand Your Hormonal and Metabolic Health

PCOS and ovarian cysts may look similar on imaging, but they require different approaches. Superpower's 100+ biomarker panel measures the hormones, metabolic markers, and inflammatory signals that distinguish between these conditions. You'll see your testosterone, insulin, glucose, and lipid levels in one comprehensive report, so you're not guessing about what's driving your symptoms. If you're managing PCOS, tracking these markers over time shows whether your interventions are improving insulin sensitivity, reducing androgens, and lowering long-term metabolic risk. If you have an isolated cyst, baseline testing confirms that your hormones and metabolism are functioning normally, giving you clarity and peace of mind.